InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by 김이랑, Executive. Officer active across 2 companies, notably 온코크로스. Cumulatively, 14 filings have been published. Regulator: DART (FSS). The full history is openly available.
14 of 14 declarations
Kim I-rang is an executive at Oncocross, a company specializing in oncology treatments. He plays a key role in managing operations and the company's strategy, contributing to its development in the market. His expertise is essential for product innovation.